Johnson & Johnson (JNJ) Invested Capital (2009 - 2026)

Johnson & Johnson's Invested Capital history runs 18 years deep, the most recent figure standing at $98.6 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 7.22% year-over-year to $98.6 billion; the TTM figure through Mar 2026 stood at $98.6 billion (up 7.22% YoY), while the FY2025 annual figure was $123.0 billion, up 18.38% from the prior year.
• Invested Capital came in at $98.6 billion for Q1 2026 at Johnson & Johnson, down from $123.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $123.0 billion in Q4 2025 to a low of $74.6 billion in Q3 2024.
• A 5-year average of $90.3 billion and a median of $88.5 billion in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital retreated 11.57% in 2024 and gained 18.38% in 2025, its largest moves.
• Johnson & Johnson's Invested Capital stood at $79.0 billion in 2022, then rose by 21.64% to $96.1 billion in 2023, then climbed by 8.08% to $103.9 billion in 2024, then rose by 18.38% to $123.0 billion in 2025, then dropped by 19.79% to $98.6 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $98.6 billion, $123.0 billion, and $85.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison